European Insurers Outperform as War-Risk Stocks Lag

Context

European insurance stocks have outpaced the broader market in the opening months of 2026, with the STOXX Europe 600 Insurance index registering roughly an 11% gain year-to-date through March 27, 2026, versus a c.5% rise in the STOXX Europe 600 benchmark (Investing.com, Mar 27, 2026). That relative strength has persisted despite elevated geopolitical risk — particularly the prolonged conflict in Eastern Europe and renewed tensions in the Middle East — which might be expected to widen loss expectations for insurers. Instead, investor focus has centered on insurer balance-sheet resilience, improving underwriting results in 2025, and reinsurance market dynamics that have shifted the sector's earnings profile. Market participants are re-pricing idiosyncratic risk and rewarding capital adequacy and predictable underwriting cash flows, producing a sector-level rerating relative to cyclical and growth‑oriented peers.

This contextual backdrop is important because insurance is both a cyclical and defensive sector: underwriting cycles, catastrophe losses and investment returns interact to drive earnings volatility. In 2025 many European life and P&C groups reported improved operating metrics and raised dividend payouts or share buybacks, which supported equity demand. Regulators' enforcement of Solvency II capital standards and the post-pandemic recovery in investment income have also buttressed confidence in insurer solvency; for instance, several large groups reported Solvency II ratios above 200% as of year-end 2025 (company disclosures, Q4 2025). The market's reaction so far implies investors prefer insurers with visible capital buffers and credible catastrophe reinsurance programmes over more opaque exposures to battlefield or attritional losses.

For institutional investors assessing sector allocation, the current divergence raises two central questions: whether the outperformance is durable given episodic war-related losses and how much of the rally is valuation catch-up versus structural improvement in industry fundamentals. The subsequent sections provide a data-driven interrogation of those issues and contrast the sector's performance with broader European equities and selected financial peers.

Data Deep Dive

Performance and valuation metrics underpin the case for insurers' outperformance. According to Investing.com data dated Mar 27, 2026, the STOXX Europe 600 Insurance index was up c.11% YTD while the STOXX Europe 600 was up c.5% YTD, representing an approximate 6-percentage-point outperformance in the first quarter of 2026 (Investing.com, Mar 27, 2026). Price-to-book multiples for the sector have expanded modestly: aggregate P/B for listed European insurers moved from ~1.05 at the end of 2025 to ~1.18 by late March 2026 (market aggregate, Bloomberg and company disclosures, Q1 2026), narrowing the discount versus the long-term average but still below pre-2019 peaks. Dividend yields remain attractive relative to broader financials, with several major insurers offering yields in the 4–6% range as of Q1 2026 (company investor relations pages, Q1 2026).

Underwriting and capital metrics show constructive trends. Public filings for 2025 indicate combined ratios improved in many P&C operations: a number of large European P&C underwriters reported combined ratios in the mid-90s for 2025 versus high-90s to low-100s in 2024 (company annual reports, 2025). Solvency II ratios — the regulator-calculated capital buffer for European insurers — were reported above 200% at year-end 2025 for several systemically important firms, providing room for capital returns or incremental risk-taking (company Q4 2025 disclosures). Reinsurance market conditions also tightened across several lines in the 2025 renewals, with brokers and reinsurers reporting average treaty price increases in the low-to-mid teens percent range for high-severity lines (Guy Carpenter/Marsh renewal surveys, 2025), which benefits primary insurers that secured favourable terms or limited their catastrophe retention.

Investment portfolios are another driver. With short-term interest rates remaining elevated relative to the previous decade, insurers have been able to lock in higher yields on fixed-income investments. European insurers' allocation to fixed income rose modestly in 2025, and the reported average yield on new fixed-income purchases was in the 3–4% band for much of 2025 (company disclosures, 2025). That incrementally strengthens net investment income, narrowing the revenue gap versus historical norms and cushioning underwriting volatility. Investors are factoring both stable near-term cash flows and the ability to reinvest at higher rates into equity valuations.

Sector Implications

The divergence between insurers and broader markets has tangible implications for capital allocation and M&A activity. Improved capital positions and predictable cash generation have enabled large insurers to pursue buybacks and bolt-on acquisitions without materially increasing leverage; a number of transactions and buyback announcements were recorded in H2 2025 and Q1 2026 across Continental Europe and the UK (company press releases, Q4 2025–Q1 2026). This behaviour contrasts with many industrials and growth companies that remain capital-constrained or are seeing multiple compression due to higher discount rates. For insurers, capital redeployment has been a visible channel of shareholder returns and a near-term contributor to EPS growth.

Peer comparison dynamics are important: reinsurers and specialty insurers have outperformed generalist life franchises in some markets because reinsurance pricing strength directly lifts near-term revenue, while life insurers remain exposed to guaranteed-rate liabilities and longer duration mismatches. For example, reinsurer indices recorded double-digit returns in parts of 2025–2026 renewal cycles (Guy Carpenter market notes, 2025–2026), whereas several life insurers saw muted share-price response despite solid solvency metrics. This split highlights that market participants are paying a premium for clear earnings catalysts — reinsurance pricing and short-dated P&C earnings — versus longer-dated liability-management stories.

Regulatory and political dynamics remain a differentiator across jurisdictions. Insurers with large U.S. casualty exposures or concentrated property portfolios in catastrophe-prone regions trade differently than diversified European-only players. Market participants are increasingly incorporating scenario analysis — including severe tail events tied to armed conflict — into valuations and stress testing. This has elevated the value of transparent loss-reserving practices and third-party reinsurance contracts in investor assessments.

Risk Assessment

The sector's outperformance should not be interpreted as immunity to downside; there are identifiable risks that could reverse recent gains. Sovereign or systemic shocks that produce large-scale insured losses — for example, escalation of hostilities affecting energy infrastructure or critical chokepoints — could result in elevated catastrophe claims above current market assumptions. Historical precedent, such as industry losses in 2017–2018 from large natural catastrophes, demonstrates how quickly underwriting results can swing negative and compress equity multiples. Investors must therefore weigh the current balance-sheet strength against event-driven volatility.

Market-level risks also include a potential re-pricing of credit markets. If sovereign or corporate spreads widen materially, insurers' fixed-income portfolios could incur mark-to-market losses that depress capital ratios, particularly for firms with significant mid-duration exposure. Although many insurers have increased long-duration matching and hedging strategies, the liquidity impacts in a stressed environment can force asset sales or conservative reserving that stress earnings. These transmission mechanisms are salient when assessing carry and convexity in insurer portfolios.

Operational and litigation risks are non-trivial. War-related claims often entail complex coverage disputes around war exclusions, attritional losses, and supply-chain interruptions; protracted legal battles could amplify loss recognition timelines and increase reserve uncertainty. Furthermore, cyber exposures related to geopolitical actors impose another growing category of potential claims that is not always fully priced into current premiums. Management transparency, contract drafting quality and reinsurance governance are therefore key risk indicators.

Outlook

Through the remainder of 2026, the insurance sector's trajectory will hinge on three variables: frequency and severity of insured losses tied to geopolitical events, the trajectory of interest rates and reinvestment yields, and reinsurance market developments. If reinsurance rates remain firmer and investment yields stay above the multi-year average, insurers can sustain higher returns on capital and maintain capital distribution programmes. Conversely, a material escalation of conflict zones could trigger reserve adjustments and re-rating. Investors should monitor industry renewal cycles closely — mid-year treaty renewals and quarterly earnings through Q3 2026 will be critical timing events.

Relative valuation suggests there is limited room for a broad-based rerating absent continued fundamental improvement: sector P/B has expanded but remains below pre-pandemic highs, and consensus EPS growth for 2026–2027 incorporates continued investment income gains (analyst consensus, Q1 2026). Active managers seeking exposure to structural insurance themes should prioritize balance-sheet strength and corporate governance, while tactical long-short strategies may exploit dispersion between reinsurers, P&C carriers and life franchises. For those considering sector tilts, stress-testing portfolios under plausible adverse geopolitical and rate scenarios is imperative.

Investors can deepen their analysis with specialist research; for further thematic work on financials and insurance, see our Fazen insights portal on topic and our sector methodology papers at topic.

Fazen Capital Perspective

Fazen Capital views the current outperformance as selective rather than universal. Our proprietary screening of European insurers prioritizes solvency buffers, conservative reserving practices and transparent catastrophe modelling. We observe that market participants have rewarded those companies with Solvency II ratios comfortably above 150–200% and clear reinsurance strategies. That said, our models assign a premium only where capital deployment is disciplined: buybacks funded by recurring free cash flow receive higher conviction than one-off capital returns following capital-ratio improvements.

A contrarian insight from our desk is that the market may be under-weighting duration mismatches as a source of secular risk for life insurers. While near-term reinvestment at higher yields boosts income, structural guarantees and the legacy asset-liability duration gap can reassert themselves if rates fall or curve dynamics invert. We therefore prefer franchise re-pricing and product simplification as durable earnings drivers over episodic investment returns. Fazen's sector work suggests tilting toward P&C underwriters with diversified portfolios and conservative catastrophe retentions provides a better asymmetric risk-reward in the current cycle.

Finally, investors should consider active engagement on disclosure and reserving practices. Insurance accounting can mask downside through reserve discounting and changes in actuarial assumptions. Firms that commit to higher disclosure quality and third-party loss analytics have systematically traded at narrower discounts in our historical analysis. See additional background in our research archive for institutional readers at topic.

FAQ

Q: How have reinsurance renewals in 2025–26 affected primary insurers' earnings?

A: Renewal surveys by major brokers in 2025 indicated treaty price increases in the low-to-mid teens percent range for many high-severity lines, improving primary underwriters' pricing power (Guy Carpenter/Marsh, 2025). That step-up in reinsurance pricing has had a two-fold effect: it raised ceded costs where primary insurers retained existing treaties, but it also allowed insurers negotiating new programmes to transfer tail risk more cheaply relative to prior cycles, effectively lowering required capital for catastrophe exposures.

Q: Is the sector's outperformance durable relative to other financials, such as banks?

A: Durability depends on the persistence of higher reinvestment yields and the absence of large-scale insured losses. Banks and insurers face different sensitivities — banks are more credit-sensitive and interest-rate sensitive via net interest margins, whereas insurers combine underwriting and investment risks. Year-to-date to Mar 27, 2026, insurers have outperformed banks on a sector basis as measured by the STOXX Europe 600 subindices (Investing.com, Mar 27, 2026), but historical cycles show reversals are possible when catastrophe losses materialize or when investment spreads compress.

Bottom Line

European insurers' Q1 2026 outperformance reflects stronger underwriting outcomes, elevated reinvestment yields and tighter reinsurance pricing, but the rally is conditional on limited escalation of geopolitical losses and continued capital discipline. Investors should emphasize balance-sheet metrics and transparent reserving when allocating to the sector.

Disclaimer: This article is for informational purposes only and does not constitute investment advice.